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Abstract
Global gene-expression analyses of human embryonic stem cells confirm the involvement of some
known genes in stem-cell function and identify some new candidate regulators of stem-cell
growth. Support remains elusive, however, for the concept of ‘stemness’ - a pattern of
expression of genes that is common to all stem cells. 
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Embryonic stem (ES) cells are truly remarkable because of
their ability both to renew themselves and to give rise to all
the cells in the body. The ability to generate a wide range of
differentiated cell types defines them as pluripotent. Human
ES cells could be an incredible resource for the treatment of
human disease. Differentiated cells derived from them could
potentially be used to treat a wide variety of human condi-
tions, including (but not limited to) heart disease, diabetes,
stroke, Alzheimer’s disease and Parkinson’s disease. Several
major hurdles remain to be overcome if such cells are to be
used clinically, however. Stated simply, we know very little
about their basic physiology or their true potential. What
factors are required for their survival and proliferation?
What factors can maintain them in a pluripotent state? What
growth conditions affect their differentiation? 
One way to address these questions is to analyze gene
expression in ES cells. The goal is straightforward: if we can
identify the full panoply of genes expressed in human ES
cells and compare this with data from other stem-cell and
non-stem-cell populations, it might be possible to define
what makes ES cells unique. Such genes might be the ones
that maintain ES cells in a self-renewing, pluripotent state.
Knowledge of the genes expressed in ES cells could also have
some very practical uses. For example, knowing that human
ES cells express certain growth factor receptors could help in
devising strategies to improve the growth of the cells in
culture. Analyzing gene expression in human ES cells could
provide critical insights into the cell-surface receptors
involved in growth control, cell-substrate adhesion and cell-cell
adhesion in these and other cell types, and into intracellular
signaling pathways involved in their basic physiology. 
Several recent papers [1-5] have now reported global
gene-expression analyses of a variety of human ES-cell
lines (summarized in Table 1 and Figure 1). The datasets
give important new insights into the basic physiology of
these incredible cells. Several of the studies also compare the
human ES-cell gene-expression datasets with published data
from mouse ES cells [2,4,5] or with data derived from
human embryonal carcinoma (EC) cells (the pluripotent
stem cells derived from testicular tumors) or from seminomas
(germ-cell-derived testicular tumor cells) [1]. Comparison of
the genes that each study lists as candidates for involvement
in self-renewal or pluripotency reveals both similarities and
differences in gene-expression patterns among human
ES-cell lines. The results include some tantalizing tidbits of
information but also provide a cautionary tale for future
research on ES cells. 
The human ES-cell transcriptome 
The data generated by the five groups [1-5] provide important
confirmation of old ideas as well as providing support for
some newly emerging concepts. For example, compelling
evidence from studies carried out in mice [6] had previouslydemonstrated a critical role for the POU domain transcription
factor Oct4 (also called Pou5F1) in controlling the stability of
the pluripotent state [6]. Encouragingly, all the studies [1-5]
found high levels of expression of this factor in human ES
cells. Also included in the list of genes enriched in human ES
cells is the human homolog of the mouse Nanog gene. Nanog
was recently found to be important for maintaining pluripo-
tency in mouse ES cells [7,8]; deciphering the role of NANOG
in human ES cells will therefore be of great interest. Interest-
ingly, components of the leukemia inhibitory factor (LIF)
pathway do not appear to be enriched in human ES cells, con-
sistent with the observed lack of response by human ES cells
to LIF, despite the fact that activation of the LIF pathway
allows self renewal of mouse cells. Two additional enriched
genes encode members of the transforming growth factor
superfamily, LeftyA and LeftyB. These factors have been gen-
erally overlooked in stem-cell studies but now clearly warrant
more attention. New insights into ES cell biology will emerge
from analysis and functional testing of the candidates. 
Comparison of the datasets from different human ES-cell lines
suggests that each line has a unique gene-expression profile.
For example, the data from Abeyta et al. [4] show differences
between lines: more than 20% of the approximately 14,000
genes found were expressed in only one of the three lines
examined (see Figure 1d). What accounts for these differences
in gene expression among human ES-cell lines? One possible
explanation is genetic diversity. The genetic diversity present
in the human population, represented to some degree in the
available human ES cells, could affect gene-expression profiles
among the cell lines. The expression of a gene can be affected
by genetic polymorphisms in the gene itself or in modifier loci.
The effects of modifier loci are well known to mouse geneti-
cists and certainly act in human populations as well [9]. The
growing list of available human ES-cell lines could be used to
address the role that genetic diversity plays in regard to differ-
ential gene expression [10].
Genetic diversity may be part of the answer but is not likely to
be the whole story. Differences in the purity of the cell popula-
tions used as the source of mRNA in the different studies
could also account for some of the variation observed. The
optimal conditions for maintaining human ES cells in an
undifferentiated state are still not fully defined. For this
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Table 1
Comparison of different methods and approaches for the analysis of human ES-cell gene expression
Sperger et al. [1] Sato et al. [2] Richards et al. [3] Abeyta et al. [4] Zeng et al. [5]
Human ES-cell lines used  H1, H7, H9, H13, H14 H1 HES3, HES4 H9, HSF-1, HSF-6 BG01, BG02
Culture conditions MEFs Matrigel MEFs  MEFs MEFs
Method of ES-cell  Treatment with  Treatment with  Microdissection  Mechanical dissection  Trypsinization
isolation  collagenase until  dispase until cells  to free colonies  of colonies from MEFs, 
colonies lifted off  were free of MEFs of MEFs then collagenase 
the MEFs treatment
Arrays used  Stanford microarrays Affymetrix arrays  SAGE Affymetrix arrays  Custom 16,659-spot 70-bp
(hU133A and mouse  (hU133A and hU133B) oligonucleotide array
U74Av2)
Cells compared hEC, hES and  hES and published hES and hES and  hES and hES versus hES and hES versus mES [28]
seminoma mES [16] additional SAGE  published mES [16]
libraries [24]
Primary subtraction  Somatic and cancer  Differentiated  None None Pooled human RNA 
method  cell lines hES cells
Software/analysis used Significance analysis of  dChip and MAS  Comparison of two  MAS 5.0 (Affymetrix) Gene Pix (Axon 
microarrays (SAM) [25] 4.0 (Affymetrix) SAGE resources with  Instruments)
SAGE 2000 [26,27]
Number of genes   1,760 918 8,341 7,385 373
enriched in human ES cells
Candidate pluripotency  565 227 192 76 92
genes*
Confirmation of gene  RT-PCR RT-PCR RT-PCR Quantitative RT-PCR RT-PCR
expression using
*Candidate pluripotency genes are defined as genes that are found only in all pluripotent cell lines examined in each study. Abbreviations: hEC, human
embryonal carcinoma cells; hES, human embryonic stem cells; MEFs, mouse embryonic fibroblasts; mES, mouse embryonic stem cells; RT-PCR,
reverse-transcriptase-coupled PCR; SAGE, serial analysis of gene expression. reason, it seems possible that some of the variation in gene
expression among human ES-cell lines may arise because the
mRNA pools that were used contained not only ES-cell mRNA
but also mRNA from differentiated derivatives. It is also worth
noting that the behavior of the various cell lines can be quite
different. Some lines are amenable to bulk culture, while
others are not; some lines can be grown in feeder-independent
culture, while others cannot; and some lines spontaneously
differentiate, while others do not [11,12]. Culture conditions
can affect gene imprinting, which in turn could have dramatic
effects on gene expression. Variation in gene-expression pat-
terns among human ES-cell lines could also reflect differences
in the developmental stage represented by each line. If the cell
lines are developmentally different - even slightly - then differ-
ent gene-expression profiles could be observed. Indeed, REX1,
an Oct4 target gene, and FOXD3, a gene required for develop-
ment of pluripotent ES cells in mice, were enriched in some
ES-cell lines but not others. 
The stem-cell orchestra 
One of the most challenging - yet crucial - unanswered
questions regarding human ES cells is how they can be
maintained in a pluripotent state. By comparing the gene-
expression profiles of pluripotent stem cells with those of
other cell types, several of the groups [1-5] attempted to find
genes whose expression could be unique to pluripotent stem
cells; some have termed these the “stem-cell orchestra” [13].
One notable inclusion in the list of genes expressed by all
human ES-cell lines is that encoding the transcription factor
Oct4 mentioned above, consistent with its known role in
maintaining pluripotency. Several other genes that have been
associated with pluripotent cells are found in many of the
datasets, including genes encoding Sox2, Nanog, Foxd3 and
members of extracellular signaling pathway families includ-
ing fibroblast (FGF), Wnt and bone morphogenetic protein
(BMP).
All the studies [1-5] included lists of candidate genes that may
play an important role in self-renewal and/or pluripotency.
One perplexing observation is the lack of overlap among the
gene lists. In part, this could result from the different sub-
traction methods used to removed genes expressed in non-
ES cells from the datasets (see Table 1). Although there is
unlikely to be one ‘correct’ method of subtraction, the differ-
ences in approach undoubtedly make comparison of results
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Figure 1
Comparison of the numbers of genes found to be enriched in human ES-cell lines in the five studies [1-5]. The circles each represent the number of
genes found to be enriched in each cell line; the inner light circles represent genes shared with mouse cell lines (mouse genes not shared with human cell
types are omitted). (a) Sperger et al. [1] compared five human ES-cell lines with seminoma and embryonal carcinoma (EC) cells and found 330 genes in
common between them all. (b) Sato et al. [2] found 227 genes in common between human and mouse ES cells. (c) Richards et al. [3] found 192 genes
that were upregulated in human ES cells compared with other human and mouse SAGE libraries. (d) Abeyta et al. [4] found 76 genes in common
between three human ES-cell lines and mouse ES cells. (e) Zeng et al. [5] found 92 genes in common between two human ES-cell lines and mouse ES
cells. In (b-d), the inner light circles represent the number of candidate pluripotency genes; in (a), candidate pluripotency genes are those shared by
human ES and EC cells but not seminoma cells (565 genes).
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(d) (e)complicated. Analysis is further complicated by the need to
set a level of gene expression that is considered enriched or
not enriched. In most of the studies [1,2,4,5], the authors
chose to make the cut-off at two-fold to 3.5-fold; genes that
show expression differences above these cut-offs were
defined as enriched. It seems likely, however, that some of
the most important players in the stem-cell orchestra may
play a very soft tune. Indeed, studies have shown that
changes in Oct4 expression of less than two-fold can have
profound effects on mouse ES-cell fate [14]. The arbitrary
cut-off levels set by the authors [1,2,4,5] could exclude some
of the key genes. Microarray analysis is also hampered by the
‘lamp-post effect’ - that is, only being able to see things
where the light shines (microarray analysis excludes genes
not present on the array). Thus, the studies that used
microarray analysis [1,2,4,5] were able to identify only the
genes with enriched expression in human ES cells that are
present on the arrays. Importantly, one of the studies [3]
used serial analysis of gene expression (SAGE). This tech-
nique avoids both the need for an arbitrary cut-off to define
transcript enrichment and the lamp-post effect. It enables
both quantitative characterization of gene expression and
identification of novel splice variants, novel exons and novel
genes [3,15].
A cautionary tale
In the last few years, the concept of ‘stemness’ has been
introduced - the idea that different stem-cell populations,
whether pluripotent or not, will share gene-expression sig-
natures [16,17]. Can global gene-expression analysis
provide new insights into this concept? It is difficult to
answer this from the existing reports [1-5]. One idea that
needs to be considered is that some of the genes that may be
required to establish stemness may not be required to
maintain that state. It also seems quite plausible that stem
cells use pathways and molecules that are used elsewhere in
non-stem-cell populations. A case in point is the STAT3
gene, whose activity is sufficient for the maintenance of
murine ES cells as stem cells. Activation of STAT3 in mouse
ES cells is brought about by LIF acting through gp130. This
pathway is certainly not unique to stem cells, however, and
plays important roles in many other aspects of development
and adult homeostasis. 
The recent gene-expression studies [1-5], nevertheless,
provide a rich resource to gain important new insights into
the physiology of human ES cells and provide an enormous
amount of information that deserves our attention. But
therein lies the difficulty: using microarray and SAGE
approaches to examine gene expression is relatively easy, but
deciphering gene function can be very difficult. How can gene
function in human ES cells be determined? Altering gene
expression by transfection or homologous recombination in
human ES cells is technically difficult. Homologous recombi-
nation has been achieved in human ES cells but, to date,
there is only one published report of its use [18]. Moreover,
some studies on gene function may require targeting of both
alleles of a gene, a task that is wrought with difficulties even
in mouse ES cells. Introducing genes into human ES cells
with lentiviral vectors has been demonstrated and promises
to be a workable technique [19-21]. RNA interference does
work in human ES cells, but what is not yet clear is whether
the effects are stable and whether true nulls (with no expres-
sion) are produced in addition to hypomorphs (with reduced
expression) [2,23]. Nonetheless, such an approach may be
useful for an initial examination of gene function. 
Incremental advances in growing human ES cells in an
undifferentiated state are likely to follow from the recent
gene-expression studies [1-5]. The technology for manipulat-
ing the cells will improve, and this in turn will aid our ability
to carry out analysis of gene function in human ES cells.
Gradually we will begin to understand what gives these cells
their unique properties, gene by gene. It may seem tedious,
but consider the alternatives. If human ES cells had been
discovered a decade earlier, some of the approaches now
used would not have been available. The sequencing of the
human genome has allowed us to examine the complexity of
gene expression in a way that was inconceivable ten years
ago. Discoveries made using additional genome-wide
approaches may finally allow us to see beyond the light cast
by microarrays and deeper into the mysteries of stemness. 
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